Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.53 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.41 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1095121 | 0.84 | ESR1 (0.61) | ESR1ESR2ABHD6MTNR1BNQO2 | |
| SCHEMBL1095554 | 0.84 | ESR1 (0.61) | ESR1ESR2ABHD6MTNR1BNQO2 | |
| SCHEMBL4551325 | 0.83 | ESR1 (0.55) | ESR1ESR2ABHD6MTNR1BNQO2 | |
| SCHEMBL1094619 | 0.81 | ESR1 (0.62) | ESR1ESR2ABHD6MTNR1BMTNR1A | |
| SCHEMBL1095538 | 0.78 | ESR1 (0.65) | ESR1ESR2ABHD6MTNR1BHSD11B1 | |
| SCHEMBL4937667 | 0.78 | ESR1 (0.65) | ESR1ESR2ABHD6MTNR1BHSD11B1 | |
| SCHEMBL1095164 | 0.76 | ESR1 (0.61) | ESR1ESR2ABHD6MTNR1BNQO2 | |
| SCHEMBL6656989 | 0.75 | ESR1 (0.60) | ESR1ESR2ABHD6MTNR1BHSD11B1 | |
| SCHEMBL1094365 | 0.72 | ESR1 (0.47) | ESR1ESR2ABHD6MTNR1BNQO2 | |
| SCHEMBL2309023 | 0.72 | ESR1 (0.85) | ESR1ESR2ABHD6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2111859-A1 | 5HT2C receptor modulator compositions and methods of use | Arena Pharmaceuticals, Inc. (US) | 2009-10-28 | — | — | EP | disclosed |